VIVEK RAMASWAMY is a Republican primary contender for 2024.
But what is the politician’s history? What we know about his parents is as follows.
Who is Vivek Ramaswamy?
Vivek Ramaswamy was born in Cincinnati, Ohio on August 9, 1985.
He received a Bachelor of Arts, summa cum laude in biology from Harvard College in 2007 and a Juris Doctor from Yale in 2013.
He interned at Amaranth Advisors, a hedge fund, and Goldman Sachs, an investment bank.
Strive, an asset management firm based in Ohio, was launched by him in 2022.
He stated his desire to run for President of the United States in February 2023.
Ramaswamy is a Republican who has given his own campaign $10.55 million.
He’s also a published author, having penned Woke, Inc. and Nation Of Victims.
Apoorva Tewari is Ramaswamy’s wife, and the couple has two children.
Who are Vivek Ramaswamy’s parents?
Vivek was born in India to Hindu Tamil immigrants.
His father, V. Ganapathy Ramaswamy, graduated from the National Institute of Technology Calicut and worked for General Electric as an engineer and patent attorney.
Geetha Ramaswamy, his mother, was a geriatric psychiatrist who graduated from Mysore Medical College & Research Institute.
His parents came from the Palakkad area of Kerala, India.
Vivek’s family has an ancestral home in Vadakkencherry, a typical agraharam.
He spent numerous summer holidays with his folks in India.
His father told News18 Malayalam: “Ours is a regular family. Vivek has been an ambitious boy since his childhood.
“Both he and his younger brother have had an interest in Indian culture.”
Vivek said his father gave him good advice in life, telling him: “If you’re going to stand out, then you might as well be outstanding.”
How did Vivek Ramaswamy become a billionaire?
Vivek was already affluent at the time due to his engagement in the banking, pharmaceutical, and biotech industries.
Before graduating from law school, Vivek revealed in 2013 that he had a net worth of roughly $15 million.
While at Harvard, Vivek co-founded StudentBusinesses.com.
The platform was designed for student entrepreneurs to pitch professional investors.
The Ewing Marion Kauffman Foundation purchased it in 2009 for an undisclosed fee.
Vivek joined the hedge fund QVT after graduation, where he focused on pharmaceutical investing.
He earned $7 million in the first seven years of his career and became a partner at the age of 28.
Vivek quit QVT at the age of 29 and founded Roviant Sciences, a biotechnology startup, in 2014.
Roivant’s objective was to develop medications that had been abandoned by other pharmaceutical companies.
He launched Roivant subsidiary Axovant in 2015.
Its most valuable asset was an Alzheimer’s medication called Intepirdine, which Vivek purchased for $5 million.
However, it was a letdown when it failed a clinical testing two years later.
Vivek declared more than $38 million in capital gains on his tax return when Axovant entered the New York Stock Exchange.
The company was renamed Sio Gene Therapies in 2020 and is currently valued $30 million.
Vivek had other medications, and in 2020, Sumitomo Dinippon paid $3 billion for five of them as well as a 10% share in Roivant.
Vivek declared a $176 million income on his tax return that year, which includes $174.5 million in capital gains.
Vivek resigned from his company in January 2021, citing “increasing public engagement” with his shareholders as the reason.
Vivek stepped down as CEO of Roivant in 2021 and entered politics.
He wrote the book Woke, Inc, which critiqued corporate America’s rising emphasis on
A year later, Vivek launched Strive, a “anti-woke” index fund provider.
Strive was valued at $300 million, implying that Vivek’s investment is worth roughly $100 million.
